Page last updated: 2024-08-23

nigericin and Gout

nigericin has been researched along with Gout in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, SY; He, XH; Li, YP; Liang, QQ; Ou-Yang, DY; Shi, ZJ; Xu, LH; Xu, R; You, YP; Yuan, T; Zha, QB; Zhang, HR1
Avouac, J; Bennana, E; Chiocchia, G; Devauchelle, V; Ea, HK; Gonzalez, V; Gottenberg, JE; Guillonneau, F; Mistou, S; Mouasni, S; Schmitt, A; Tourneur, L1

Other Studies

2 other study(ies) available for nigericin and Gout

ArticleYear
Theaflavin mitigates acute gouty peritonitis and septic organ injury in mice by suppressing NLRP3 inflammasome assembly.
    Acta pharmacologica Sinica, 2023, Volume: 44, Issue:10

    Topics: Adenosine Triphosphate; Animals; Antioxidants; Caspases; Gout; Inflammasomes; Interleukin-1beta; Mice; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Peritonitis; Reactive Oxygen Species; Sepsis

2023
The classical NLRP3 inflammasome controls FADD unconventional secretion through microvesicle shedding.
    Cell death & disease, 2019, 02-25, Volume: 10, Issue:3

    Topics: Animals; Arthritis, Rheumatoid; Caspase 1; Cell Line, Tumor; Cell-Derived Microparticles; Fas-Associated Death Domain Protein; Gout; Humans; Immunity, Innate; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Monocytes; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Potassium Channels; Pyroptosis

2019